Top View
- ARAF Recurrent Mutation Causes Central Conducting Lymphatic Anomaly Treatable with a MEK Inhibitor
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- 3-Phosphoinositide-Dependent Protein Kinase-1 As an Emerging Target in the Management of Breast Cancer
- Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
- Associations Between Mutations of the Cell Cycle Checkpoint Kinase 2 Gene and Gastric Carcinogenesis
- List of Actionable Genes and Potential Matched Therapy
- Cancer Susceptibility Mutations in Patients with Urothelial Malignancies the Following Represents Disclosure Information Provided by Authors of This Manuscript
- A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
- Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer Xia Wang1, Roope A
- CHEK2 Gene Mutation Analysis Assay Summary
- Transposon Insertional Mutagenesis in Mice Identifies Human Breast Cancer Susceptibility Genes and Signatures for Stratification
- CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather Than Checkmate
- Prevalence of Germline Mutations in Cancer Susceptibility Genes In
- Absence of EIF1AX, PPM1D, and CHEK2 Mutations Reported in Thyroid Cancer Genome Atlas (TCGA) in a Large Series of Thyroid Cancer
- CHEK2 Clinical Guide
- CHEK2 Pathogenic Variants in Greek Breast Cancer Patients
- Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-To-CMMRD Phenotypic Continuum
- Realtime Ready Plate Layout Human Cell Cycle Regulation Panel, 96
- Findings from the Breast Cancer Association Consortium Taru A
- Probe Set ID Gene Symbol Gene Name Refseq Transcript ID Chrom . Loc. 1007 S at DDR1 Discoidin Domain Receptor Family, Member
- CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors
- Epistatic Relationship Between the Cancer Susceptibility Genes CHEK2 and P27
- The CHEK2 Gene and Inherited Breast Cancer Susceptibility
- Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy Via Differential Modulation of BRAF Activity Christina Stangl1,2, Jasmin B
- Le Ciblage De B-RAF
- CHEK2, PCA, and the CELL CYCLE White Paper No 134 February, 2016
- Genetic Variability in the Microrna Binding Sites of BMPR1B, TGFBR1, IQGAP1, KRAS, SETD8 and RYR3 and Risk of Breast Cancer in Colombian Women
- Identification of Potential Synthetic Lethal Genes Ot P53 Using a Computational Biology Approach
- Family-Wide Structural Analysis of Human Numb- Associated Protein Kinases
- The Contribution of Hereditary Cancer-Related Germline Mutations to Lung Cancer Susceptibility
- Scanmaxsm Kinase Assay Panel
- Rare Germ Line CHEK2 Variants Identified in Breast Cancer Families Encode Proteins That Show Impaired Activation
- Supplementary Appendix 1
- Cell Cycle Kinases As Therapeutic Targets for Cancer
- Identification of Potential Synthetic Lethal Genes to P53 Using a Computational Biology Approach Xiaosheng Wang1* and Richard Simon2*
- Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
- BRCA1/2 Analyses with Cancernext® Variant of Unknown Significance
- Characterization and Clustering of Kinase Isoform Expression in Metastatic Melanoma
- Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
- Current Perspectives on CHEK2 Mutations in Breast Cancer
- Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
- Classifying Variants in the CHEK2 Gene
- Germline Variants in Cancer Genes in High-Risk Non-BRCA Patients from Puerto Rico Julie Dutil1*, Jamie K
- S2 Table. Next-Generation Sequencing Panel Gene Lists
- Repression of Mrna for the PLK Cell Cycle Gene After DNA Damage Requires BRCA1
- Regulators of the RAS-ERK Pathway As Therapeutic Targets in Thyroid Cancer
- CHEK2 Contribution to Hereditary Breast Cancer in Non-BRCA Families Alexis Desrichard2, Yannick Bidet2, Nancy Uhrhammer1 and Yves-Jean Bignon1,2*
- New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome Leah J
- Profiling Data